Skip to main content
    R

    Reviva Pharmaceuticals Holdings Inc. (RVPH)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • PINK

    $0.35
    -0.00 (-0.82%)

    Market Cap: $4.63M

    Last updated: Nov 16, 2026 at 4:00 PM ET

    Reviva Pharmaceuticals Holdings Inc. (RVPH) Statistics

    Updated Nov 16, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Reviva Pharmaceuticals Holdings (RVPH) has a market cap of $4.63M. It holds $17.41M more cash than debt, 376.00% of its market cap.

    Total Valuation

    Market Cap$4.63M
    Close (Nov 16, 2026)$0.35

    Key Dates

    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026.

    Shares Outstanding13.21M
    Shares Change (QoQ)0.00%

    Price Statistics

    The stock is down 96.76% over 52 weeks and trades 23.91% below its 50-day average.

    Beta (1Y)1.41
    52-Week Change-96.76%
    1-Month Change-25.53%
    3-Month Change-23.83%
    6-Month Change-14.54%
    5-Year Change-99.50%
    Total Return (1Y)-96.76%
    Total Return (3Y CAGR)-83.67%
    Total Return (5Y CAGR)-65.12%
    Max Drawdown (1Y)-97.72%
    Max Drawdown (3Y)-99.70%
    Sharpe Ratio (1Y)-1.95
    Correlation with SPY (1Y)0.11
    50-Day Average$0.46
    200-Day Average$1.18
    52-Week Range$0.26 to $15.40
    RSI (14 Days)42.0
    Average Volume (20 Days)34.54K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.39x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio3.39x
    Quick Ratio3.39x
    Debt / Equity0.00x
    Interest Coverage-2302.37x

    Returns and Efficiency

    Return on invested capital is -90.21% and return on equity is -86.48% over the last 12 months.

    Return on Equity (ROE)-86.48%
    Return on Assets (ROA)-60.95%
    Return on Invested Capital (ROIC)-90.21%

    Scores

    RVPH has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$11.88M
    Pretax Income-$11.30M
    Net Income-$11.31M
    Reported EPS (TTM)-$6.01

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 70.47% of the $18.56M in total assets.

    Cash and Equivalents$17.46M
    Total Debt$44.39K
    Net Cash$17.41M
    Net Cash Per Share$1.32
    Working Capital$13.08M
    Shareholder Equity$13.08M
    Book Value Per Share$0.99
    Total Assets$18.56M
    Total Liabilities$5.48M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$13.90M
    FCF Per Share-$1.06

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    RVPH does not pay a dividend.

    Buyback Yield-246.20%
    Shareholder Yield-246.20%

    Stock Splits

    The last split was a 1-for-20 reverse split on Mar 9, 2026.

    Last Split DateMar 9, 2026
    Split TypeReverse split
    Split Ratio1:20

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About RVPH

    What is RVPH's market cap?

    Reviva Pharmaceuticals Holdings has a market cap of $4.63M.

    How many shares of RVPH are outstanding?

    Reviva Pharmaceuticals Holdings has 13.21M shares outstanding.

    Does RVPH pay a dividend?

    No. Reviva Pharmaceuticals Holdings does not pay a dividend.

    How much debt does RVPH have?

    Reviva Pharmaceuticals Holdings has $44.39K of total debt and $17.46M of cash and equivalents, a net cash position of $17.41M.